{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T15:40:04Z","timestamp":1794238804225,"version":"4.9.0"},"reference-count":47,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171313"],"award-info":[{"award-number":["82171313"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271338"],"award-info":[{"award-number":["82271338"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82301492"],"award-info":[{"award-number":["82301492"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2023ZD0505200"],"award-info":[{"award-number":["2023ZD0505200"]}]},{"DOI":"10.13039\/501100008750","name":"Shanghai Municipal Hospital Development Center","doi-asserted-by":"publisher","award":["SHDC2022CRD032"],"award-info":[{"award-number":["SHDC2022CRD032"]}],"id":[{"id":"10.13039\/501100008750","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Stroke Vasc Neurol"],"accepted":{"date-parts":[[2025,10,11]]},"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>Moyamoya disease (MMD) is a chronic, occlusive cerebrovascular disorder with no unified management guidelines. This consensus aims to provide updated, evidence-based recommendations for the diagnosis and treatment of MMD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We integrated recent findings from epidemiology, genetics and imaging studies\u2014particularly those published since 2017\u2014along with expert input from over 20 clinical centres. Advances in diagnostic criteria, treatment strategies and perioperative management were reviewed and incorporated to update the 2017 consensus.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Refinements in diagnosis include high-resolution imaging and revised Suzuki staging supplemented by new collateral circulation grading. Treatment strategies emphasise individualised surgical planning, especially extracranial-intracranial bypass, and pharmacological management targeting ischaemic events, cognitive decline and collateral vessel formation. Perioperative care focuses on managing complications such as transient neurological dysfunction and stroke through haemodynamic monitoring and timely imaging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This updated consensus underscores the value of early diagnosis using advanced imaging, personalised interventions and standardised perioperative care. This initiative aims to enhance clinical outcomes and health-related quality of life in MMD patients, offering a contemporary, evidence-based approach to managing MMD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/svn-2024-003925","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T10:00:13Z","timestamp":1764842413000},"page":"406-414","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Chinese expert consensus on the treatment and diagnosis of moyamoya disease and moyamoya syndrome (2024)"],"prefix":"10.1136","volume":"11","author":[{"given":"Wei","family":"Ni","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Huashan Hospital Fudan University, Shanghai, Shanghai, China"},{"name":"National Center for Neurological Disorders, Shanghai, China"},{"name":"Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration, Shanghai, China"},{"name":"Neurosurgical Institute of Fudan University, Shanghai, China"},{"name":"Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8055-115X","authenticated-orcid":false,"given":"Jiabin","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Huashan Hospital Fudan University, Shanghai, Shanghai, China"},{"name":"National Center for Neurological Disorders, Shanghai, China"},{"name":"Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration, Shanghai, China"},{"name":"Neurosurgical Institute of Fudan University, Shanghai, China"},{"name":"Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchao","family":"Fei","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Huashan Hospital Fudan University, Shanghai, Shanghai, China"},{"name":"National Center for Neurological Disorders, Shanghai, China"},{"name":"Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration, Shanghai, China"},{"name":"Neurosurgical Institute of Fudan University, Shanghai, China"},{"name":"Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4580-2205","authenticated-orcid":false,"given":"Yuxiang","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Huashan Hospital Fudan University, Shanghai, Shanghai, China"},{"name":"National Center for Neurological Disorders, Shanghai, China"},{"name":"Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration, Shanghai, China"},{"name":"Neurosurgical Institute of Fudan University, Shanghai, China"},{"name":"Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Mao","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Huashan Hospital Fudan University, Shanghai, Shanghai, China"},{"name":"National Center for Neurological Disorders, Shanghai, China"},{"name":"Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration, Shanghai, China"},{"name":"Neurosurgical Institute of Fudan University, Shanghai, China"},{"name":"Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4919-5390","authenticated-orcid":false,"given":"Shuo","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"key":"2026082702101051000_11.4.406.1","doi-asserted-by":"crossref","first-page":"e917","DOI":"10.1016\/j.wneu.2018.10.175","article-title":"Epidemiology of Moyamoya Disease in China: Single-Center, Population-Based Study","volume":"122","author":"Bao","year":"2019","journal-title":"World Neurosurg"},{"key":"2026082702101051000_11.4.406.2","article-title":"Epidemiology of Moyamoya disease in China: A nationwide hospital-based study","volume":"18","author":"Zhang","year":"2022","journal-title":"Lancet Reg Health West Pac"},{"key":"2026082702101051000_11.4.406.3","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.113.004160"},{"key":"2026082702101051000_11.4.406.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2009.11.009"},{"key":"2026082702101051000_11.4.406.5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022542","article-title":"Identification of RNF213 as a Susceptibility Gene for Moyamoya Disease and Its Possible Role in Vascular Development","volume":"6","author":"Liu","year":"2011","journal-title":"PLoS ONE"},{"key":"2026082702101051000_11.4.406.6","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23094492","article-title":"Novel Multifaceted Roles for RNF213 Protein","volume":"23","author":"Pollaci","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2026082702101051000_11.4.406.7","first-page":"541","article-title":"\u5f90\u658c, \u987e\u5b87\u7fd4. \u70df\u96fe\u75c5\u548c\u70df\u96fe\u7efc\u5408\u5f81\u8bca\u65ad\u4e0e\u6cbb\u7597\u4e2d\u56fd\u4e13\u5bb6\u5171\u8bc6 (2017","volume":"33","year":"2017","journal-title":"Chin Neurosurg J"},{"key":"2026082702101051000_11.4.406.8","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00165-X"},{"key":"2026082702101051000_11.4.406.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105339"},{"key":"2026082702101051000_11.4.406.10","doi-asserted-by":"crossref","first-page":"e2896","DOI":"10.1212\/WNL.0000000000012049","article-title":"Pearls & Oy-sters: Moyamoya Vasculopathy and Its Association With Congenital Heart Disease","volume":"96","author":"Osterloh","year":"2021","journal-title":"Neurology"},{"key":"2026082702101051000_11.4.406.11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1600-0404.1996.tb00552.x","article-title":"Xe-CT in cerebrovascular disease and moyamoya disease","volume":"93","author":"Suzuki","year":"1996","journal-title":"Acta Neurol Scand"},{"key":"2026082702101051000_11.4.406.12","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/neuros\/nyx140","article-title":"Berlin Grading System Can Stratify the Onset and Predict Perioperative Complications in Adult Moyamoya Disease","volume":"81","author":"Kashiwazaki","year":"2017","journal-title":"Neurosurgery"},{"key":"2026082702101051000_11.4.406.13","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.119.024487"},{"key":"2026082702101051000_11.4.406.14","doi-asserted-by":"crossref","first-page":"578","DOI":"10.7150\/ijms.15390","article-title":"Progress on Complications of Direct Bypass for Moyamoya Disease","volume":"13","author":"Yu","year":"2016","journal-title":"Int J Med Sci"},{"key":"2026082702101051000_11.4.406.15","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.3390\/brainsci12101285","article-title":"Risk Factors of Transient Neurological Deficits and Perioperative Stroke after Revascularization in Patients with Moyamoya Disease","volume":"12","author":"Zhang","year":"2022","journal-title":"Brain Sci"},{"key":"2026082702101051000_11.4.406.16","doi-asserted-by":"crossref","first-page":"5726","DOI":"10.1038\/s41598-022-26985-3","article-title":"Risk factors and a novel cerebral infarction extent scoring system for postoperative cerebral ischemia in patients with ischemic Moyamoya disease","volume":"13","author":"Chen","year":"2023","journal-title":"Sci Rep"},{"key":"2026082702101051000_11.4.406.17","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.wneu.2019.11.065","article-title":"Cerebral Hyperperfusion Syndrome After Revascularization Surgery in Patients with Moyamoya Disease: Systematic Review and Meta-Analysis","volume":"135","author":"Yu","year":"2020","journal-title":"World Neurosurg"},{"key":"2026082702101051000_11.4.406.18","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1007\/s00259-024-06995-1","article-title":"The cerebellar glucose metabolism in moyamoya vasculopathy and its correlation with neurocognitive performance after cerebral revascularization surgery: a [18F]FDG PET study","volume":"52","author":"Weng","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026082702101051000_11.4.406.19","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3171\/2018.10.JNS182152","article-title":"dl-3-n-butylphthalide for alleviation of neurological deficit after combined extracranial-intracranial revascularization for moyamoya disease: a propensity score-matched analysis","volume":"132","author":"Li","year":"2020","journal-title":"J Neurosurg"},{"key":"2026082702101051000_11.4.406.20","doi-asserted-by":"crossref","first-page":"1132339","DOI":"10.3389\/fneur.2023.1132339","article-title":"Benefits and risks of antiplatelet therapy for moyamoya disease","volume":"14","author":"Liu","year":"2023","journal-title":"Front Neurol"},{"key":"2026082702101051000_11.4.406.21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/23969873221144089","article-title":"European Stroke Organisation (ESO) Guidelines on Moyamoya angiopathy Endorsed by Vascular European Reference Network (VASCERN)","volume":"8","author":"Bersano","year":"2023","journal-title":"Eur Stroke J"},{"key":"2026082702101051000_11.4.406.22","doi-asserted-by":"crossref","first-page":"S4628","DOI":"10.4103\/jpbs.jpbs_1085_24","article-title":"Clinical Outcomes and Stroke Recurrence in Moyamoya Disease Post-Revascularization: A Retrospective Analysis","volume":"16","author":"Alhumaid","year":"2024","journal-title":"J Pharm Bioallied Sci"},{"key":"2026082702101051000_11.4.406.23","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.608000","article-title":"Efficacy and Safety of Antiplatelet Agents for Adult Patients With Ischemic Moyamoya Disease","volume":"11","author":"Ye","year":"2020","journal-title":"Front Neurol"},{"key":"2026082702101051000_11.4.406.24","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1080\/01616412.2019.1580455","article-title":"Cilostazol may improve cognition better than clopidogrel in non-surgical adult patients with ischemic moyamoya disease: subanalysis of a prospective cohort","volume":"41","author":"Ando","year":"2019","journal-title":"Neurol Res"},{"key":"2026082702101051000_11.4.406.25","doi-asserted-by":"crossref","DOI":"10.3171\/2023.7.FOCUS23327","article-title":"Cilostazol for the management of moyamoya disease: a systematic review of the early evidence, efficacy, safety, and future directions","volume":"55","author":"Abedi","year":"2023","journal-title":"Neurosurg Focus"},{"key":"2026082702101051000_11.4.406.26","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000475"},{"key":"2026082702101051000_11.4.406.27","doi-asserted-by":"publisher","DOI":"10.1136\/svn-2022-001985"},{"key":"2026082702101051000_11.4.406.28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.wneu.2016.10.117","article-title":"Surgical Outcome for Moyamoya Disease: Clinical and Perfusion Computed Tomography Correlation","volume":"98","author":"Cheung","year":"2017","journal-title":"World Neurosurg"},{"key":"2026082702101051000_11.4.406.29","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2022.966430","article-title":"Surgical techniques and indications for treatment of adult moyamoya disease","volume":"9","author":"Nguyen","year":"2022","journal-title":"Front Surg"},{"key":"2026082702101051000_11.4.406.30","doi-asserted-by":"publisher","DOI":"10.1055\/s-2005-868160"},{"key":"2026082702101051000_11.4.406.31","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1469-8749.2011.04144.x","article-title":"Intellectual ability and executive function in pediatric moyamoya vasculopathy","volume":"54","author":"Williams","year":"2012","journal-title":"Dev Med Child Neurol"},{"key":"2026082702101051000_11.4.406.32","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3340\/jkns.2015.57.6.440","article-title":"Cognitive Outcome of Pediatric Moyamoya Disease","volume":"57","author":"Shim","year":"2015","journal-title":"J Korean Neurosurg Soc"},{"key":"2026082702101051000_11.4.406.33","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.3389\/fneur.2019.01308","article-title":"Cognitive Performance Profile in Pediatric Moyamoya Disease Patients and Its Relationship With Regional Cerebral Blood Perfusion","volume":"10","author":"Li","year":"2019","journal-title":"Front Neurol"},{"key":"2026082702101051000_11.4.406.34","doi-asserted-by":"crossref","first-page":"1502318","DOI":"10.3389\/fnhum.2024.1502318","article-title":"Cognitive dysfunction in Moyamoya disease: latest developments and future directions","volume":"18","author":"Wang","year":"2024","journal-title":"Front Hum Neurosci"},{"key":"2026082702101051000_11.4.406.35","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2176\/jns-nmc.2021-0382","article-title":"2021 Japanese Guidelines for the Management of Moyamoya Disease: Guidelines from the Research Committee on Moyamoya Disease and Japan Stroke Society","volume":"62","author":"Fujimura","year":"2022","journal-title":"Neurol Med Chir(Tokyo)"},{"key":"2026082702101051000_11.4.406.36","doi-asserted-by":"crossref","first-page":"975","DOI":"10.3171\/2024.1.JNS221977","article-title":"Management of moyamoya disease: a review of current and future therapeutic strategies","volume":"141","author":"Kappel","year":"2024","journal-title":"J Neurosurg"},{"key":"2026082702101051000_11.4.406.37","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000443"},{"key":"2026082702101051000_11.4.406.38","doi-asserted-by":"crossref","first-page":"234","DOI":"10.7150\/ijms.10837","article-title":"Treatment Strategies for Aneurysms Associated with Moyamoya Disease","volume":"12","author":"Zhang","year":"2015","journal-title":"Int J Med Sci"},{"key":"2026082702101051000_11.4.406.39","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.114.005624"},{"key":"2026082702101051000_11.4.406.40","doi-asserted-by":"publisher","DOI":"10.3171\/2014.8.JNS132176"},{"key":"2026082702101051000_11.4.406.41","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3171\/2009.3.JNS08837","article-title":"Clinical features, surgical treatment, and long-term outcome in adult patients with moyamoya disease","volume":"111","author":"Starke","year":"2009","journal-title":"JNS"},{"key":"2026082702101051000_11.4.406.42","doi-asserted-by":"publisher","DOI":"10.3171\/2016.11.JNS161688"},{"key":"2026082702101051000_11.4.406.43","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1190934","article-title":"2023 Chinese guideline for lipid management","volume":"14","author":"Li","year":"2023","journal-title":"Front Pharmacol"},{"key":"2026082702101051000_11.4.406.44","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jocn.2020.07.016","article-title":"Clinical outcomes after revascularization for pediatric moyamoya disease and syndrome: A single-center series","volume":"79","author":"Morshed","year":"2020","journal-title":"J Clin Neurosci"},{"key":"2026082702101051000_11.4.406.45","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1007\/s00381-023-06017-9","article-title":"Technical evolution of pediatric neurosurgery: moyamoya disease","volume":"39","author":"Kim","year":"2023","journal-title":"Childs Nerv Syst"},{"key":"2026082702101051000_11.4.406.46","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3171\/2017.10.JNS171749","article-title":"Risk factors for and outcomes of postoperative complications in adult patients with moyamoya disease","volume":"130","author":"Zhao","year":"2019","journal-title":"J Neurosurg"},{"key":"2026082702101051000_11.4.406.47","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.3171\/2019.7.JNS19885","article-title":"Postoperative hemorrhage during the acute phase after direct or combined revascularization for moyamoya disease: risk factors, prognosis, and literature review","volume":"133","author":"Chen","year":"2020","journal-title":"J Neurosurg"}],"container-title":["Stroke and Vascular Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/svn-2024-003925","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T09:10:41Z","timestamp":1787821841000},"score":1,"resource":{"primary":{"URL":"https:\/\/svn.bmj.com\/lookup\/doi\/10.1136\/svn-2024-003925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":47,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8,27]]},"published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1136\/svn-2024-003925"],"URL":"https:\/\/doi.org\/10.1136\/svn-2024-003925","relation":{},"ISSN":["2059-8688","2059-8696"],"issn-type":[{"value":"2059-8688","type":"print"},{"value":"2059-8696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,4]]}}}